Published in J Chromatogr B Biomed Sci Appl on December 01, 2000
New spectrofluorimetric method with enhanced sensitivity for determination of paroxetine in dosage forms and plasma. Anal Chem Insights (2008) 0.82
Simple spectrophotometric method for determination of paroxetine in tablets using 1,2-naphthoquinone-4-sulphonate as a chromogenic reagent. Int J Anal Chem (2009) 0.81
Spectrophotometric Determination of the Antidepressants Sertraline and Paroxetine HCl using 2,4-Dinitrofluorobenzene. Int J Biomed Sci (2010) 0.78
Artificial Neural Networks (ANN) for the Simultaneous Spectrophotometric Determination of Fluoxetine and Sertraline in Pharmaceutical Formulations and Biological Fluid. Iran J Pharm Res (2017) 0.75
International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev (1998) 4.37
Cartilage injuries: a review of 31,516 knee arthroscopies. Arthroscopy (1997) 3.54
The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract (2001) 3.48
Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett (1993) 3.38
The prevalence of chronic pelvic pain in women in the United Kingdom: a systematic review. Br J Obstet Gynaecol (1998) 2.18
Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry (2001) 2.11
Chronic pelvic pain in the community--symptoms, investigations, and diagnoses. Am J Obstet Gynecol (2001) 2.01
Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics (2011) 1.96
Obstetric ultrasound scanning by local health workers in a refugee camp on the Thai-Burmese border. Ultrasound Obstet Gynecol (2009) 1.80
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol (2010) 1.74
Prevalence and incidence of chronic pelvic pain in primary care: evidence from a national general practice database. Br J Obstet Gynaecol (1999) 1.68
Self-report ratings and informants' ratings of personalities of depressed outpatients. Am J Psychiatry (1998) 1.67
Views on classification and diagnosis of eating disorders. Can J Psychiatry (1995) 1.66
The objectives, design and implementation of the INTERGROWTH-21st Project. BJOG (2013) 1.61
Dioxin pollution and endometriosis in Belgium. Hum Reprod (1994) 1.59
Comparisons of men with full or partial eating disorders, men without eating disorders, and women with eating disorders in the community. Am J Psychiatry (2001) 1.50
Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. Neuron (1989) 1.50
Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity. Can J Psychiatry (2001) 1.49
Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neurosci (1990) 1.46
First- and second-trimester tests to predict stillbirth in unselected pregnant women: a systematic review and meta-analysis. BJOG (2014) 1.43
A controlled assessment of direct intraperitoneal insemination. Fertil Steril (1992) 1.42
Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. J Clin Psychiatry (1991) 1.39
Metabolic aspects of obesity. Adv Metab Disord (1970) 1.38
Caesarean hysterectomy for intrauterine death after failed endometrial resection. Br J Obstet Gynaecol (1994) 1.37
The role of physical activity in the development and maintenance of eating disorders. Psychol Med (1994) 1.36
A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem (1997) 1.29
Malaria in pregnancy: the difficulties in measuring birthweight. BJOG (2011) 1.26
Major depression in individuals with a history of childhood physical or sexual abuse: relationship to neurovegetative features, mania, and gender. Am J Psychiatry (1998) 1.22
Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update (2010) 1.21
Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Hum Reprod Update (2011) 1.21
Lower dopamine transporter binding potential in striatum during depression. Neuroreport (2001) 1.20
Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG (2011) 1.18
Reducing child uncooperative behavior during dental treatment through modeling and reinforcement. J Appl Behav Anal (1980) 1.16
Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism (1968) 1.16
Coronary heart disease mortality among Arab and Jewish residents of Jerusalem. Lancet (2000) 1.14
Endometriosis in monozygotic twins. Fertil Steril (1997) 1.13
Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis. BJOG (2013) 1.12
The clinician-investigator interface in psychiatry I--Values and problems. Can J Psychiatry (1989) 1.12
The clinician-investigator interface in psychiatry: II--The role of the Clinical Investigation Unit. Can J Psychiatry (1989) 1.12
Cerebral gray matter volume deficits after weight recovery from anorexia nervosa. Arch Gen Psychiatry (1997) 1.10
Metabolism of amphetamines. Identification of N-oxygenated products by gas chromatography and mass spectrometry. J Pharm Pharmacol (1973) 1.10
Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update (1999) 1.08
The genetic basis of endometriosis. Curr Opin Obstet Gynecol (2001) 1.07
Obsessive compulsiveness and physical activity in anorexia nervosa and high-level exercising. J Psychosom Res (1995) 1.07
Familial Kallmann syndrome with unilateral renal aplasia. Clin Genet (1975) 1.06
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study. Int Clin Psychopharmacol (2004) 1.06
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans. Neurosci Biobehav Rev (1999) 1.04
Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl) (1998) 1.04
Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol. Cell Mol Neurobiol (1997) 1.01
Self-report symptoms that predict major depression in patients with prominent physical symptoms. Int J Psychiatry Med (1990) 1.00
Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology (2000) 0.99
Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex. Neuropharmacology (1996) 0.98
Reversed neurovegetative symptoms of depression: a community study of Ontario. Am J Psychiatry (1997) 0.97
Anorexia nervosa and bulimia nervosa. CMAJ (1989) 0.97
Linkage and association studies of the relationship between endometriosis and genes encoding the detoxification enzymes GSTM1, GSTT1 and CYP1A1. Mol Hum Reprod (2001) 0.97
Comparative aspects of lipogenesis in mammalian tissues. Metabolism (1971) 0.97
An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology (Berl) (1998) 0.97
Synthesis of N-propargylphenelzine and analogues as neuroprotective agents. Bioorg Med Chem Lett (2001) 0.97
The diagnosis of major depression in renal dialysis patients. Psychosom Med (1987) 0.97
Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur J Neurosci (2008) 0.96
Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder. Neurology (2008) 0.96
The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry (2001) 0.95
Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology (2004) 0.94
Drug metabolism and atypical antipsychotics. Eur Neuropsychopharmacol (1999) 0.94
The subcellular distribution of beta-phenylethylamine, p-tyramine and tryptamine in rat brain. J Neurochem (1975) 0.94
Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica (1999) 0.94
Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points. Biol Psychiatry (1999) 0.94
Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.94
Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior. Brain Res (1986) 0.94
A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates. Mol Pharmacol (1996) 0.94
Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor. Eur J Biochem (1997) 0.93
Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci (2000) 0.93
An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatr Scand (2010) 0.93
Chirality and drugs used in psychiatry: nice to know or need to know? Cell Mol Neurobiol (1999) 0.92
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92
Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacol Biochem Behav (1994) 0.92
Use of slow-release melatonin in treatment-resistant depression. J Psychiatry Neurosci (2000) 0.92
Structural requirements for ligand interactions at the benzodiazepine recognition site of the GABA(A) receptor. J Neurochem (1998) 0.91
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Efficacy and effectiveness in the antidepressant treatment of depression: beyond metaanalysis. Can J Psychiatry (1996) 0.91
Personality factors related to the prevalence of somatic symptoms and medical complaints in a healthy student population. Br J Med Psychol (1997) 0.90
Hypothyroidism after low-dose 131 I treatment of hyperthyroidism. Ann Intern Med (1972) 0.90
The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology (Berl) (1999) 0.89
Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects. J Psychiatry Neurosci (2000) 0.89
Differentiating DSM-IV anxiety and depressive disorders in the general population: comorbidity and treatment consequences. Can J Psychiatry (2000) 0.88
Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants. Neurosci Biobehav Rev (1998) 0.88
International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown-rump length in the first trimester of pregnancy. Ultrasound Obstet Gynecol (2014) 0.88
Rumination and distraction in major depression: assessing response to pharmacological treatment. J Affect Disord (1999) 0.88
Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am J Psychiatry (1999) 0.88
Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice. Psychopharmacology (Berl) (2001) 0.87
The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. Eur Psychiatry (2011) 0.87
Molecular neurobiology of the GABAA receptor. Int Rev Neurobiol (1994) 0.87
The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers. J Clin Psychopharmacol (1995) 0.87
A gas-liquid chromatographic method for the estimation of 2-phenylethylamine in rat brain tissue. Biochem Pharmacol (1977) 0.87
Pregnancy dating by fetal crown-rump length: a systematic review of charts. BJOG (2014) 0.87
Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates. Pharm Res (1988) 0.87
p-chlorophenylalanine-induced serotonin depletion: reduction in exploratory locomotion but no obvious sensory-motor deficits. Behav Brain Res (1995) 0.87